Maximus, Inc. (NYSE:MMS) to Issue Quarterly Dividend of $0.33

Maximus, Inc. (NYSE:MMS) announced a quarterly dividend on Monday, April 6th. Investors of record on Friday, May 15th will be paid a dividend of 0.33 per share by the health services provider on Monday, June 1st. This represents a c) dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Friday, May 15th.

Maximus has increased its dividend payment by an average of 0.0%annually over the last three years and has raised its dividend every year for the last 2 years. Maximus has a dividend payout ratio of 19.8% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.32 annual dividend with an expected future payout ratio of 22.9%.

Maximus Price Performance

NYSE:MMS traded up $1.22 during trading hours on Monday, hitting $63.60. 588,349 shares of the company’s stock traded hands, compared to its average volume of 720,670. Maximus has a 52 week low of $60.75 and a 52 week high of $100.00. The business’s fifty day simple moving average is $75.75 and its two-hundred day simple moving average is $83.38. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. The firm has a market cap of $3.47 billion, a P/E ratio of 9.68 and a beta of 0.63.

Maximus (NYSE:MMS) last announced its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The company’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.61 EPS. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, research analysts anticipate that Maximus will post 6.15 earnings per share for the current fiscal year.

Insider Transactions at Maximus

In other news, CEO Bruce Caswell bought 3,175 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was bought at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the transaction, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at $25,732,619.85. This represents a 0.98% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jan Madsen sold 742 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the completion of the sale, the director directly owned 20,795 shares of the company’s stock, valued at approximately $1,502,438.75. This represents a 3.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Maximus

A number of hedge funds have recently made changes to their positions in the business. Farther Finance Advisors LLC boosted its stake in shares of Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 116 shares in the last quarter. Richardson Financial Services Inc. lifted its stake in Maximus by 123.1% in the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after purchasing an additional 192 shares during the last quarter. Advisory Services Network LLC bought a new stake in Maximus in the third quarter worth $32,000. Canada Pension Plan Investment Board purchased a new stake in Maximus during the second quarter valued at about $35,000. Finally, Cullen Frost Bankers Inc. purchased a new stake in Maximus during the third quarter valued at about $38,000. 97.21% of the stock is currently owned by institutional investors.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.